scholarly article | Q13442814 |
P356 | DOI | 10.1152/JAPPLPHYSIOL.00056.2003 |
P953 | full work available at URL | http://intl-jap.physiology.org/cgi/content/abstract/95/2/672 |
https://www.physiology.org/doi/pdf/10.1152/japplphysiol.00056.2003 | ||
P698 | PubMed publication ID | 12692138 |
P5875 | ResearchGate publication ID | 10807874 |
P2093 | author name string | Haydee M. Vercesi | |
John A. Hey | |||
Nansie A. McHugh | |||
Robert W. Egan | |||
P2860 | cites work | Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1 | Q22306225 |
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 | ||
RANK is essential for osteoclast and lymph node development | Q24598872 | ||
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification | Q24603266 | ||
Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families | Q28137631 | ||
Regulation of the differentiation and function of osteoclasts | Q34010151 | ||
Changes in bone mineral density with age in men and women: a longitudinal study | Q34119625 | ||
Perimenopausal risk of falling and incidence of distal forearm fracture | Q35712526 | ||
TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. | Q36404187 | ||
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism | Q37108966 | ||
Basic biomechanical measurements of bone: a tutorial | Q40797364 | ||
Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency | Q40868586 | ||
Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat. | Q41352329 | ||
In vivo rat assay: bone remodeling and steroid effects on juvenile bone by pQCT quantification in 7 days | Q44185357 | ||
Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice | Q46092958 | ||
Age-related changes in the tensile properties of cortical bone. The relative importance of changes in porosity, mineralization, and microstructure | Q46296154 | ||
Deficient acquisition of bone during maturation underlies idiopathic osteoporosis in men: evidence from a three-generation family study | Q49034316 | ||
Intracapsular hip fracture and the region-specific loss of cortical bone: analysis by peripheral quantitative computed tomography. | Q52059123 | ||
RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β | Q57675150 | ||
Peak bone mass | Q72176094 | ||
Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation | Q74411385 | ||
A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro | Q77342999 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | physiology | Q521 |
P304 | page(s) | 672-676 | |
P577 | publication date | 2003-04-11 | |
P1433 | published in | Journal of Applied Physiology | Q1091719 |
P1476 | title | Receptor activator of NF-κB ligand arrests bone growth and promotes cortical bone resorption in growing rats | |
P478 | volume | 95 |